IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IRA DANIEL HARBER

Allopathic & Osteopathic Physicians Dermatology

NPI
1922539071
CMS profile
5697867
Location
CORINTH, MS

General Payments · PY2018–2024

$5,054.93

  • Reported across 241 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,374.81

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Dermatology MS All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,085.57 49
Education $289.24 3

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $448.35 9
E.R. Squibb & Sons, L.L.C. $230.87 9
NOVARTIS PHARMACEUTICALS CORPORATION $130.94 11
Regeneron Healthcare Solutions, Inc. $99.26 1
SUN PHARMACEUTICAL INDUSTRIES INC. $88.38 4
Lilly USA, LLC $70.39 3
UCB, Inc. $68.50 3
Amgen Inc. $63.74 3
ABBVIE INC. $55.18 3
PFIZER INC. $41.04 2
Galderma Laboratories, L.P. $21.32 1
LEO Pharma Inc. $19.93 1
Boehringer Ingelheim Pharmaceuticals, Inc. $19.16 1
Ortho Dermatologics, a division of Bausch Health US, LLC $17.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $91.60 1
PY2019 $254.85 7
PY2020 $26.24 1
PY2021 $1,128.74 49
PY2022 $1,023.00 57
PY2023 $1,155.69 74
PY2024 $1,374.81 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.33 02/29/2024 Food and Beverage Undisputed 01/23/2026 1103878180 CMS
ABBVIE INC. $17.56 04/17/2024 Food and Beverage Undisputed 01/23/2026 1103878182 CMS
ABBVIE INC. $24.29 05/29/2024 Food and Beverage Undisputed 01/23/2026 1103878184 CMS
Amgen Inc. $21.16 08/14/2024 Food and Beverage Undisputed 01/23/2026 1117271349 CMS
Amgen Inc. $21.22 10/02/2024 Food and Beverage Undisputed 01/23/2026 1117271351 CMS
Amgen Inc. $21.36 11/21/2024 Food and Beverage Undisputed 01/23/2026 1117271353 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.16 11/14/2024 Food and Beverage Undisputed 01/23/2026 1118237656 CMS
E.R. Squibb & Sons, L.L.C. $25.32 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101532005 CMS
E.R. Squibb & Sons, L.L.C. $20.86 03/25/2024 Food and Beverage Undisputed 01/23/2026 1101532032 CMS
E.R. Squibb & Sons, L.L.C. $13.31 04/23/2024 Food and Beverage Undisputed 01/23/2026 1101532056 CMS
E.R. Squibb & Sons, L.L.C. $12.74 05/21/2024 Food and Beverage Undisputed 01/23/2026 1101532077 CMS
E.R. Squibb & Sons, L.L.C. $20.74 06/12/2024 Food and Beverage Undisputed 01/23/2026 1101532091 CMS
E.R. Squibb & Sons, L.L.C. $116.10 07/25/2024 Food and Beverage Undisputed 01/23/2026 1101532195 CMS
E.R. Squibb & Sons, L.L.C. $2.73 10/22/2024 Food and Beverage Undisputed 01/23/2026 1101532232 CMS
E.R. Squibb & Sons, L.L.C. $18.07 11/19/2024 Food and Beverage Undisputed 01/23/2026 1101532259 CMS
E.R. Squibb & Sons, L.L.C. $1.00 11/19/2024 Food and Beverage Undisputed 01/23/2026 1101532263 CMS
Galderma Laboratories, L.P. $21.32 09/11/2024 Food and Beverage Undisputed 01/23/2026 1145302685 CMS
Janssen Biotech, Inc. $29.04 04/18/2024 Food and Beverage Undisputed 01/23/2026 1078802249 CMS
Janssen Biotech, Inc. $9.92 04/24/2024 Food and Beverage Undisputed 01/23/2026 1078802350 CMS
Janssen Biotech, Inc. $99.99 05/09/2024 Education Undisputed 01/23/2026 1078802285 CMS
Janssen Biotech, Inc. $16.49 05/09/2024 Food and Beverage Undisputed 01/23/2026 1078802290 CMS
Janssen Biotech, Inc. $149.06 06/20/2024 Food and Beverage Undisputed 01/23/2026 1078802333 CMS
Janssen Biotech, Inc. $37.98 06/22/2024 Food and Beverage Undisputed 01/23/2026 1078802277 CMS
Janssen Biotech, Inc. $10.68 09/30/2024 Food and Beverage Undisputed 01/23/2026 1078802202 CMS
Janssen Biotech, Inc. $89.99 10/22/2024 Education Undisputed 01/23/2026 1078802375 CMS
Janssen Biotech, Inc. $5.20 11/05/2024 Food and Beverage Undisputed 01/23/2026 1078802299 CMS
LEO Pharma Inc. $19.93 11/18/2024 Food and Beverage Undisputed 01/23/2026 1152633275 CMS
Lilly USA, LLC $19.71 01/23/2024 Food and Beverage Undisputed 01/23/2026 1135028088 CMS
Lilly USA, LLC $33.00 02/15/2024 Food and Beverage Undisputed 01/23/2026 1135009249 CMS
Lilly USA, LLC $17.68 10/23/2024 Food and Beverage Undisputed 01/23/2026 1135008821 CMS
Novartis Pharmaceuticals Corporation $10.14 01/08/2024 Food and Beverage Undisputed 01/23/2026 1086813939 CMS
Novartis Pharmaceuticals Corporation $11.50 02/27/2024 Food and Beverage Undisputed 01/23/2026 1086813935 CMS
Novartis Pharmaceuticals Corporation $24.31 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086813943 CMS
Novartis Pharmaceuticals Corporation $7.25 04/23/2024 Food and Beverage Undisputed 01/23/2026 1086813953 CMS
Novartis Pharmaceuticals Corporation $3.56 04/23/2024 Food and Beverage Undisputed 01/23/2026 1086813955 CMS
Novartis Pharmaceuticals Corporation $20.89 05/14/2024 Food and Beverage Undisputed 01/23/2026 1086813951 CMS
Novartis Pharmaceuticals Corporation $1.36 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086813959 CMS
Novartis Pharmaceuticals Corporation $23.08 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086813961 CMS
Novartis Pharmaceuticals Corporation $3.56 06/10/2024 Food and Beverage Undisputed 01/23/2026 1086813957 CMS
Novartis Pharmaceuticals Corporation $21.47 07/12/2024 Food and Beverage Undisputed 01/23/2026 1086813965 CMS
Novartis Pharmaceuticals Corporation $3.82 07/12/2024 Food and Beverage Undisputed 01/23/2026 1086813967 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $17.75 03/08/2024 Food and Beverage Undisputed 01/23/2026 1153809923 CMS
PFIZER INC. $22.60 04/01/2024 Food and Beverage Undisputed 01/23/2026 1131684451 CMS
PFIZER INC. $18.44 04/01/2024 Food and Beverage Undisputed 01/23/2026 1131708672 CMS
Regeneron Healthcare Solutions, Inc. $99.26 10/31/2024 Education Undisputed 01/23/2026 1114065112 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $23.20 04/24/2024 Food and Beverage Undisputed 01/23/2026 1152154619 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $20.76 07/10/2024 Food and Beverage Undisputed 01/23/2026 1152154621 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $15.66 09/12/2024 Food and Beverage Undisputed 01/23/2026 1152154623 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $28.76 11/13/2024 Food and Beverage Undisputed 01/23/2026 1152154625 CMS
UCB, Inc. $24.02 07/11/2024 Food and Beverage Undisputed 01/23/2026 1143509472 CMS
UCB, Inc. $18.17 07/25/2024 Food and Beverage Undisputed 01/23/2026 1143509478 CMS
UCB, Inc. $26.31 10/30/2024 Food and Beverage Undisputed 01/23/2026 1143509485 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.